The Application of Ursodeoxycholic Acid for the Prevention of SARS-CoV-2 Infection (COVID-19)
Clinical trial NCT05659654 · COMPLETED
Trial details
- NCT number
- NCT05659654
- Sponsor
- Institute of Hematology & Blood Diseases Hospital, China
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-16
- Primary completion
- 2023-03-03
- Enrollment
- 95
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.